You are here

  • Home
  • Archive
  • Volume 11, Issue 10
  • Adjuvant therapy in completely resected, EGFR-mutant non-small cell lung cancer: a comparative analysis of treatment efficacy between EGFR-TKI and anti-PD-1/PD-L1 immunotherapy

Article metrics

Article menu
Commentary
Adjuvant therapy in completely resected, EGFR-mutant non-small cell lung cancer: a comparative analysis of treatment efficacy between EGFR-TKI and anti-PD-1/PD-L1 immunotherapy

 

Online download statistics by month:

Online download statistics by month: October 2023 to September 2025

AbstractFullPdf
Oct 2023390391127
Nov 2023266266129
Dec 2023201203134
Jan 202413213299
Feb 202412512577
Mar 2024179179104
Apr 2024139141105
May 202413113578
Jun 2024949570
Jul 202410610775
Aug 2024777752
Sep 2024969668
Oct 202411911988
Nov 2024140142105
Dec 2024204206143
Jan 202515715797
Feb 202520921194
Mar 202512312573
Apr 202516016086
May 2025989853
Jun 2025676847
Jul 2025110
Sep 2025110
Total321532351904